E17 ETHYLCELLULOSE. Revision 3 Stage 4

Similar documents
HYDROXYPROPYLCELLULOSE, LOW SUBSTITUTED Stage 4, Revision 1 CP: USP BRIEFING NOTE

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

Petrolatum. Stage 4, Revision 1. Petrolatum is a purified semi solid mixture of hydrocarbons obtained from petroleum.

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

MONOGRAPHS (USP) Saccharin Sodium

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Lutein Esters from Tagetes Erecta

ISOMALT. Stage 4. C 12 H 24 O 11 M r C 12 H 24 O 11, 2H 2 O M r DEFINITION

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

E55A GELATIN, GELLING GRADE Gelatina

IDENTIFICATION AND CONTROLOFRESIDUALSOLVENTS Identification and control of residual solvents EUROPEAN PHARMACOPOEIA 6.

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

Purity Tests for Modified Starches

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

VOLUNTARY MONOGRAPH. Council for Responsible Nutrition March 2006

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

Heparin Sodium ヘパリンナトリウム

BRIEFING Assay + + +

PHCH 402: Analytical Quality Control Different methods of analysis of some groups of drugs in common use in Nigeria (8 hrs)

Draft proposal for The International Pharmacopoeia

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

AMERICAN SPIKENARD FOR HOMOEOPATHIC PREPARATIONS ARALIA RACEMOSA FOR HOMOEOPATHIC PREPARATIONS

Title Revision n date

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

1 out of 8. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 86th Meeting 2018 ERYTHROSINE

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

CORESTA RECOMMENDED METHOD NÄ 9

BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

SUCROSE OLIGOESTERS TYPE I

3-Acetyldeoxynivalenol. 15-Acetyldeoxynivalenol

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

THERMALLY OXIDIZED SOYA BEAN OIL

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.

10 Sulfaquinoxaline H N O S O. 4-amino-N-quinoxalin-2-ylbenzenesulfonamide C 14 H 12 N 4 O 2 S MW: CAS No.:

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

ISOMALT. Chemical formula 6-O-alpha-D-Glucopyranosyl-D-sorbitol: C 12 H 24 O 11 1-O-alpha-D-Glucopyranosyl-D-mannitol dihydrate: C 12 H 24 O 11 2H 2 O

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

ISO INTERNATIONAL STANDARD. Animal and vegetable fats and oils Determination of individual and total sterols contents Gas chromatographic method

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016)

HEPARIN SODIUM. Heparinum natricum

STANDARD OPERATING PROTOCOL (SOP)

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

6.02 Uniformity of Dosage Units

Sucrose Esters of Fatty Acids

DETERMINATION OF COMPOSITION OF TRIACYLGLYCEROLS AND COMPOSITION AND CONTENT OF DI-ACYLGLYCEROLS BY CAPILLARY GAS CHROMATOGRAPHY, IN VEGETABLE OILS

contents of the monograph in effect today. Please refer to the current edition of the USP NF for official text.

EXPERIMENT 4 DETERMINATION OF REDUCING SUGARS, TOTAL REDUCING SUGARS, SUCROSE AND STARCH

Telmisartan and Hydrochlorothiazide Tablets. Type of Posting. Revision Bulletin Posting Date. 26 Jan 2018 Official Date

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

Final text for addition to The International Pharmacopoeia (June 2010)

COMMON BARBERRY FOR HOMOEOPATHIC PREPARATIONS BERBERIS VULGARIS FOR HOMOEOPATHIC PREPARATIONS

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

CORESTA RECOMMENDED METHOD N 8

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

By Authority Of THE UNITED STATES OF AMERICA Legally Binding Document

INTERNATIONAL ŒNOLOGICAL CODEX. PROTEIN PLANT ORIGIN FROM WHEAT, PEAS and POTATOES (OENO 28/2004, ) OIV-OENO OIV-OENO

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS

Flupyradifurone. HPLC Method

COCHINEAL FOR HOMOEOPATHIC PREPARATIONS COCCUS CACTI FOR HOMOEOPATHIC PREPARATIONS

HEPARIN SODIUM. Heparinum natricum. PA/PH/Exp. 6/T (09) 42 PUB

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

Student Practical Guide (1) Milk of Magnesia

Change to read: BRIEFING

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB1886.

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

EUDRAGIT L 100 and EUDRAGIT S 100

BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Identification B Identification C + + +

Tramadol Hydrochloride Extended-Release Tablets. Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance

Analysis of Amino Acids Derived Online Using an Agilent AdvanceBio AAA Column

METHOD 8316 ACRYLAMIDE, ACRYLONITRILE AND ACROLEIN BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)

EMTRICITABINE AND TENOFOVIR TABLETS

G/LITRE 5.0 g KOH g 0.5 g 0.05 g 0.01 g MgS047H20 NaCl CaCl2

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

INTERNATIONAL ŒNOLOGICAL CODEX. CARBOXYMETHYLCELLULOSE (cellulose gum) (CMC) INS no. 466 CAS [ ] (OIV-Oeno )

Should you have any questions, please contact Gerald Hsu, Ph.D., Senior Scientific Liaison ( or

Feedstuffs Analysis G-22-1 PROTEIN

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

ARNICA (WHOLE PLANT) FOR HOMOEOPATHIC PREPARATIONS ARNICA MONTANA FOR HOMOEOPATHIC PREPARATIONS

CLINDAMYCIN PALMITATE

Thank you for your requests under the Freedom of Information Act Please find below responses to your questions.

EASI-EXTRACT FOLIC ACID Product Code: P81 / P81B

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

Transcription:

00-205PDG.pdf 2 E7 ETHYLCELLULOSE Revision 3 Stage 4 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 9 20 2 22 23 24 25 26 27 28 29 30 3 32 33 34 35 36 37 DEFINITION Ethylcellulose is a partly O-ethylated cellulose. It contains not less than 44.0 per cent and not more than 5.0 per cent of ethoxy (-OC 2 H 5 ) groups, calculated with reference to the dried substance. It may contain a suitable antioxidant. IDENTIFICATION A. Examine by infrared absorption spectrophotometry. TESTS Acidity or alkalinity. To 0.5 g add 25 ml of carbon dioxide-free water and shake for 5 min. Filter through a sintered-glass filter (40). To 0 ml add 0. ml of phenolphthalein solution and 0.5 ml of 0.0 M sodium hydroxide. The solution is pink. To 0 ml add 0. ml of methyl red solution and 0.5 ml of 0.0 M hydrochloric acid. The solution is red. Viscosity. Shake a quantity of the substance to be examined equivalent to 5.00 g of the dried substance with 95 g of a mixture of 20 g of ethanol (96 per cent) and 80 g of toluene until the substance is dissolved. Determine the viscosity using a capillary viscometer. The viscosity, determined at 25 C and expressed in mpa.s, is not less than 80.0 per cent and not more than 20.0 per cent of that stated on the label for a nominal viscosity greater than 6 mpa.s; and not less than 75.0 per cent and not more than 40.0 per cent of that stated on the label for a nominal viscosity not greater than 6 mpa.s. Acetaldehyde. Introduce 3.0 g into a 250 ml conical flask with a ground-glass stopper, add 0 ml of water and stir mechanically for h. Allow to stand for 24 h, filter and dilute the filtrate to 00.0 ml with water. Transfer 5.0 ml to a 25 ml volumetric flask, add 5 ml of a 0.5 g/l solution of methylbenzothiazolone hydrazone hydrochloride (C 8 H 0 ClN 3 S,H 2 O) and heat in a water-bath at 60 C for 5 min. Add 2 ml of ferric chloride-sulphamic acid reagent and heat again at 60 C for 5 min. Cool and dilute to 25.0 ml with water. The solution is not more intensely coloured than a standard prepared at the same time and in the same manner using instead of the 5.0 ml of filtrate, 5.0 ml of a reference solution prepared by diluting 3.0 ml of acetaldehyde standard solution (00 ppm C 2 H 4 O) to 00.0 ml with water (00 ppm). Chlorides (0. per cent). Disperse 0.250 g in 50 ml of water, heat to boiling and allow to cool, shaking occasionally. Filter and discard the first 0 ml of the filtrate. Dilute 0 ml of the filtrate to 5 ml with water. Add ml of dilute nitric acid and pour the mixture as a single addition into a test-tube containing ml of a 7 g/l solution of silver nitrate. Prepare a standard in the same manner using 0 ml of chloride standard solution (5 ppm Cl) and 5 ml of water. Examine the tubes laterally against a black background. After standing for 5 min

2 00-205PDG.pdf 38 39 40 4 42 43 44 45 46 47 48 49 50 5 52 53 54 55 56 57 58 59 60 6 62 63 64 65 66 67 68 69 protected from light, any opalescence in the test solution is not more intense than that in the standard. Loss on drying. Not more than 3.0 per cent, determined on.000 g by drying in an oven at 05 C for 2 h. Sulphated ash. Not more than 0.5 per cent, determined on.0 g. ASSAY Gas chromatography (2.2.28). Prepare the solutions immediately before use. Internal standard solution. To 0 ml of o-xylene add 0.5 ml of n-octane and dilute to 00.0 ml with o-xylene. Test solution. To 30.0 mg of the substance to be examined, add 60 mg of adipic acid in a reaction vial. Add 2.00 ml of internal standard solution and.0 ml of hydroiodic acid and close immediately with the valve. Accurately weigh the reaction vial (total mass before heating). Place the vial in an oven or heat in a suitable heater with continuous stirring, maintaining an internal temperature of about 5 ± 2 C for 70 min. Allow to cool and weigh accurately the reaction vial (total mass after heating). If the difference of the total mass before heating to the total mass after heating is more than 0 mg, prepare a new test solution. After phase separation, pierce through the septum of the vial with a cooled syringe and withdraw a sufficient volume of the upper phase as test solution. Reference solution. Place 60 mg of adipic acid and 2.00 ml of internal standard solution in a reaction vial, add.0 ml of hydroiodic acid and close immediately with a septum. Weigh accurately the vial then inject 25 μl of iodoethane through the septum in the vial, weigh again accurately and mix. After phase separation, pierce through the septum of the vial with a cooled syringe and withdraw a sufficient volume of the upper phase as reference solution. Column: material : fused silica, size: l = 30 m, Ø = 0.53 mm, stationary phase: poly(dimethyl)siloxane (3 μm). Carrier gas : helium for chromatography. Flow rate: 4.2 ml/min. Split ratio: :40. Temperature: temperature programme as follows: RTX- Restek, DB- or HP- are suitable 2

3 00-205PDG.pdf 70 Time (min) Column 0-3 3-8 8-2.3 2.3-20.3 Temperature ( C) 50 50 00 00 250 250 Injection port 250 Detector 280 7 72 73 74 75 76 77 78 79 80 8 82 83 84 85 86 87 88 89 90 Detection: flame ionisation. Injection: μl. Relative retention with reference to n-octane (retention time = about 0 min): iodoethane: about = 0.6. System suitability: reference solution: resolution: minimum 5.0 between the peaks due to n-octane and iodoethane; relative standard deviation of the response factor of the principal peak: maximum 2.0 per cent after 6 injections. Calculate the response factor (R) from the following expression: A x W x C / A 2 x 00 A = area of the peak due to the internal standard in the chromatogram obtained with the reference A 2 = area of the peak due to iodoethane in the chromatogram obtained with the reference W = mass of iodoethane in the reference solution, in milligrams; C = percentage content of iodoethane. Calculate the percentage content m/m of the ethoxy groups from the following expression: A 4 x R x M x 00 / A 3 x W 2 x M 2 A 3 = area of the peak due to the internal standard in the chromatogram obtained with the test 3

4 00-205PDG.pdf 9 92 93 94 95 96 A 4 = area of the peak due to the iodoethane in the chromatogram obtained with the test R = response factor of iodoethane; M = molar mass of ethoxy group (45.); M 2 = molar mass of iodoethane (56.0); W 2 = mass of the sample (dried substance) in the test solution, in milligrams. 97 98 99 00 0 LABELLING The label states: - the nominal viscosity in millipascal seconds for a 5 per cent m/m - the name and concentration of any added antioxidant. 02 03 04 05 06 07 08 09 0 2 3 4 5 6 7 8 9 20 2 22 23 24 25 26 27 Reagents Phenolphthalein solution. Dissolve 0. g of phenolphthalein in 80 ml of ethanol (96 per cent) and dilute to 00 ml with water. Methyl red solution. Dissolve 50 mg in a mixture of.86 ml of 0. M sodium hydroxide and 50 ml of ethanol (96 per cent) and dilute to 00 ml with water. Ferric chloride-sulphamic acid reagent. A solution containing 0 g/l of ferric chloride (FeCl 3,6H 2 O) and 6 g/l of sulphamic acid. Acetaldehyde standard solution (00 ppm C 2 H 4 O). Dissolve.0 g of acetaldehyde in water and dilute to 00.0 ml with the same solvent. Dilute 5.0 ml of the solution to 500.0 ml with water. Prepare immediately before use. Nitric acid, dilute. Contains about 25 g/l of HNO 3 (M r 63.0). Chloride standard solution (5 ppm Cl). Immediately before use, dilute with water to 00 times its volume a solution containing sodium chloride equivalent to 0.824 g of NaCl in 000.0 ml. 4

5 00-205PDG.pdf 28 29 30 3 32 33 34 35 36 37 Iodoethane. C 2 H 5 I. (M r 55.9). [75-03-6]. Colourless or slightly yellowish liquid, darkening on exposure to air and light, miscible with ethanol (96 per cent) and most organic solvents. d 20: about.95. n 20 D : about.53. boiling point: about 72 C. Storage: in an airtight container. Content: minimum 99.0 per cent. 5